Literature DB >> 32793745

Role of Kindlin-2 in cancer progression and metastasis.

Wei Wang1,2, Urna Kansakar1,2, Vesna Markovic2, Khalid Sossey-Alaoui1,2.   

Abstract

Cancer metastasis is a complex and multistep process whereby cancer cells escape the confines of the primary site to establish a new residency at distant sites. This multistep process is also known as the invasion-metastasis cascade. The biological and molecular mechanisms that control the invasion-metastasis cascade, which ultimately leads to the spread of cancer cells into distant sites, remain poorly understood. Kindlin-2 (K2) belongs to the 4.1-ezrin-ridixin-moesin (FERM) domain family of proteins, which interact with the cytoplasmic tails of β-integrin subunits, leading to the activation of extensive biological functions. These biological functions include cell migration, differentiation, cancer initiation, development, and invasion. In this review, we will discuss the various molecular signaling pathways that are regulated by K2 during the invasion-metastasis cascade of cancer tumors. These signaling pathways include TGFβ, Wnt/β-Catenin, Hedgehog, p53 and senescence, and cancer stem cell (CSC) maintenance. We will also discuss the molecular signaling pathways that regulate K2 function both at the transcriptional and the posttranslational levels. Finally, we will consider molecular mechanisms to specifically target K2 as novel therapeutic options for cancer treatment. 2020 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Kindlin-2 (K2); cancer metastasis; signaling pathways

Year:  2020        PMID: 32793745      PMCID: PMC7396786          DOI: 10.21037/atm.2020.03.64

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  87 in total

1.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

2.  TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies.

Authors:  Tristan Courau; Djamel Nehar-Belaid; Laura Florez; Béatrice Levacher; Thomas Vazquez; Faustine Brimaud; Bertrand Bellier; David Klatzmann
Journal:  JCI Insight       Date:  2016-06-16

3.  A feedback regulation between Kindlin-2 and GLI1 in prostate cancer cells.

Authors:  Jianchao Gao; Ammad Aslam Khan; Takashi Shimokawa; Jun Zhan; Staffan Strömblad; Weigang Fang; Hongquan Zhang
Journal:  FEBS Lett       Date:  2013-01-18       Impact factor: 4.124

4.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Authors:  Philip A Gregory; Andrew G Bert; Emily L Paterson; Simon C Barry; Anna Tsykin; Gelareh Farshid; Mathew A Vadas; Yeesim Khew-Goodall; Gregory J Goodall
Journal:  Nat Cell Biol       Date:  2008-03-30       Impact factor: 28.824

Review 5.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

6.  Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS.

Authors:  Nasrin Rastgoo; Maryam Pourabdollah; Jahangir Abdi; Donna Reece; Hong Chang
Journal:  Leukemia       Date:  2018-04-24       Impact factor: 11.528

7.  Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ.

Authors:  Ling Guo; Ting Cai; Keng Chen; Rong Wang; Jiaxin Wang; Chunhong Cui; Jifan Yuan; Kuo Zhang; Zhongzhen Liu; Yi Deng; Guozhi Xiao; Chuanyue Wu
Journal:  J Cell Biol       Date:  2018-03-01       Impact factor: 10.539

8.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

9.  The Kindlin2-p53-SerpinB2 signaling axis is required for cellular senescence in breast cancer.

Authors:  Khalid Sossey-Alaoui; Elzbieta Pluskota; Dorota Szpak; Edward F Plow
Journal:  Cell Death Dis       Date:  2019-07-15       Impact factor: 8.469

10.  Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.

Authors:  Jie Lin; Wansong Lin; Yunbin Ye; Liping Wang; Xiaoyan Chen; Shengbing Zang; Aimin Huang
Journal:  J Exp Clin Cancer Res       Date:  2017-09-29
View more
  4 in total

1.  FERMT3 mediates cigarette smoke-induced epithelial-mesenchymal transition through Wnt/β-catenin signaling.

Authors:  Xiaoshan Su; Junjie Chen; Xiaoping Lin; Xiaoyang Chen; Zhixing Zhu; Weijing Wu; Hai Lin; Jianming Wang; Xiangjia Ye; Yiming Zeng
Journal:  Respir Res       Date:  2021-11-06

2.  Targeted Deletion of Kindlin-2 in Mouse Mammary Glands Inhibits Tumor Growth, Invasion, and Metastasis Downstream of a TGF-β/EGF Oncogenic Signaling Pathway.

Authors:  Wei Wang; Priyanka S Rana; Akram Alkrekshi; Katarzyna Bialkowska; Vesna Markovic; William P Schiemann; Edward F Plow; Elzbieta Pluskota; Khalid Sossey-Alaoui
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

3.  Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers.

Authors:  William L Harryman; Kendra D Marr; Ray B Nagle; Anne E Cress
Journal:  Front Cell Dev Biol       Date:  2022-03-01

4.  Kindlins as modulators of breast cancer progression.

Authors:  Edward F Plow; Elzbieta Pluskota; Katarzyna Bialkowska
Journal:  J Breast Cancer Res       Date:  2021
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.